biotin has been researched along with ebselen in 1 studies
| Studies (biotin) | Trials (biotin) | Recent Studies (post-2010) (biotin) | Studies (ebselen) | Trials (ebselen) | Recent Studies (post-2010) (ebselen) |
|---|---|---|---|---|---|
| 14,847 | 95 | 3,882 | 839 | 9 | 366 |
| Protein | Taxonomy | biotin (IC50) | ebselen (IC50) |
|---|---|---|---|
| RNA polymerase beta subunit (EC 2.7.7.6), partial | Escherichia coli | 11.6872 | |
| Arrestin, beta 1 | Homo sapiens (human) | 1.524 | |
| MPI protein | Homo sapiens (human) | 0.19 | |
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | Plasmodium berghei | 15.0867 | |
| TPA: protein transporter TIM10 | Saccharomyces cerevisiae S288C | 5.29 | |
| TPA: protein transporter TIM23 | Saccharomyces cerevisiae S288C | 0.88 | |
| hexokinase | Trypanosoma brucei brucei TREU927 | 0.9009 | |
| Spike glycoprotein | Betacoronavirus England 1 | 0.67 | |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | 0.67 | |
| neutrophil cytosol factor 1 | Homo sapiens (human) | 0.39 | |
| phosphomannomutase 2 | Homo sapiens (human) | 0.672 | |
| perilipin-5 | Homo sapiens (human) | 1.101 | |
| glucose-6-phosphate 1-dehydrogenase isoform b | Homo sapiens (human) | 13.2 | |
| phosphoethanolamine/phosphocholine phosphatase isoform 1 | Homo sapiens (human) | 0.111 | |
| perilipin-1 | Homo sapiens (human) | 3.41 | |
| eukaryotic translation initiation factor 4 gamma 1 isoform 4 | Homo sapiens (human) | 1.15 | |
| eukaryotic translation initiation factor 4E isoform 1 | Mus musculus (house mouse) | 1.15 | |
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | Homo sapiens (human) | 2.2555 | |
| Sulfhydryl oxidase 1 | Homo sapiens (human) | 5.4 | |
| Transmembrane protease serine 2 | Homo sapiens (human) | 0.67 | |
| Prostaglandin G/H synthase 1 | Bos taurus (cattle) | 2.1 | |
| Gamma-butyrobetaine dioxygenase | Homo sapiens (human) | 0.742 | |
| Bile salt export pump | Homo sapiens (human) | 10 | |
| Procathepsin L | Homo sapiens (human) | 0.67 | |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | 0.67 | |
| Replicase polyprotein 1ab | Human coronavirus 229E | 0.67 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 0.62 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.7928 | |
| Macrophage migration inhibitory factor | Homo sapiens (human) | 2.4 | |
| Insulin-degrading enzyme | Homo sapiens (human) | 0.028 | |
| Urease subunit alpha | Helicobacter pylori 26695 | 3.745 | |
| Toxin B | Clostridioides difficile | 0.0172 | |
| Caspase-1 | Homo sapiens (human) | 4.04 | |
| Bifunctional epoxide hydrolase 2 | Homo sapiens (human) | 0.7575 | |
| Methionine aminopeptidase 2 | Homo sapiens (human) | 2.43 | |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | 0.67 | |
| Urease subunit beta | Helicobacter pylori 26695 | 3.745 | |
| UDP-glucose 4-epimerase | Homo sapiens (human) | 0.014 | |
| Structural capsid protein | Human immunodeficiency virus 1 | 0.0467 | |
| Histone-lysine N-methyltransferase EHMT2 | Homo sapiens (human) | 0.4 | |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | 0.67 | |
| Histone-lysine N-methyltransferase EHMT1 | Homo sapiens (human) | 0.73 | |
| Histone deacetylase 6 | Homo sapiens (human) | 4.05 | |
| Histone deacetylase 9 | Homo sapiens (human) | 3.7 | |
| Histone deacetylase 5 | Homo sapiens (human) | 3.4 | |
| large T antigen | Betapolyomavirus macacae | 13.91 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Collares, T; da Silva, FD; Dornelles, L; Dos Santos, ACF; Garcia, FD; Leitemberger, A; Nogara, PA; Oliveira, CS; Piccoli, BC; Rocha, JBT; Rodrigues, OED; Schachtschneider, KM; Seixas, FK; Sonego, MS | 1 |
1 other study(ies) available for biotin and ebselen
| Article | Year |
|---|---|
Synthesis and biological evaluation of new antioxidant and antiproliferative chalcogenobiotin derivatives for bladder carcinoma treatment.
Topics: Antineoplastic Agents; Antioxidants; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Chalcogens; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Lipid Peroxidation; Molecular Structure; Picrates; Structure-Activity Relationship; Urinary Bladder; Urinary Bladder Neoplasms | 2020 |